Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Congrong Ma
Modifying the Cancer-Immune Set Point Using Vaccinia Virus Expressing Re-Designed Interleukin-2
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Related publications
A Vaccinia Virus Armed With Interleukin-10 Is a Promising Therapeutic Agent for Treatment of Murine Pancreatic Cancer
Clinical Cancer Research
Cancer Research
Oncology
CD40 Ligand-Expressing Recombinant Vaccinia Virus Promotes the Generation of CD8+ Central Memory T Cells
European Journal of Immunology
Allergy
Immunology
Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Construction of Live Vaccines Using Genetically Engineered Poxviruses: Biological Activity of Vaccinia Virus Recombinants Expressing the Hepatitis B Virus Surface Antigen and the Herpes Simplex Virus Glycoprotein D.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice Against Lethal Challenge
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
B5-Deficient Vaccinia Virus as a Vaccine Vector for the Expression of a Foreign Antigen in Vaccinia Immune Animals
Virology
Virology
Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
Current Diabetes Reports
Internal Medicine
Endocrinology
Metabolism
Diabetes
Recombinant Oncolytic Vaccinia Viruses Expressing Human Β-Defensin 2 Enhance Anti-Tumor Immunity
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Vaccinia Virus Motility
Annual Review of Microbiology
Microbiology
